Neoantigen-expanded Autologous Immune Cell Therapy
NCT05020119
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
Neoantigen-expanded cell therapy.
Sponsor
Chang Gung Memorial Hospital